Miura T, Miyashita Y, Hozawa K, Doijiri T, Kato T, Hayakawa N, Hashizume N, Nakano M, Ikeda U, Kuwahara K, on behalf of the ZERO Investigators. Cilostazol effectiveness in reducing drugcoated stent restenosis in the superficial femoral artery: The ZERO study. PLOS ONE. 2022. 17. 7. e0270992
Kato T, Miura T, Yamamoto S, Miyashita Y, Hashizume N, Shoin K, Sasaki S, Kanzaki Y, Yui H, Maruyama S, Nagae A, Sakai T, Saigusa T, Ebisawa S, Okada A, Motoki H, Ikeda U, Kuwahara K, REASON Investigators. Intensive exercise therapy for restenosis after superficial femoral artery stenting: the REASON randomized clinical trial. Heart Vessels. 2022. 37. 9. 1596-1603
Karashima E, Takahara M, Hozawa K, Yamauchi Y, Suzuki K, Suematsu N, Miyashita Y, Enomoto S, Tokuyama H, Murata N, Haraguchi K, Soga Y. Three-Year Clinical Outcomes of the InnovaTM Self-Expanding Nitinol Stent for the Treatment of Femoropopliteal Lesions. Cardiovasc Intervent Radiol. 2021. 44. 11. 1722-1727
Shiraki T, Takahara M, Iida O, Soga Y, Kodama A, Miyashita Y, Shintani Y, Endo M, Azuma N, SPINACH study investigators. Baseline and Updated Information on Nutritional Status in Patients With Chronic Limb Threatening Ischaemia Undergoing Revascularisation. Eur J Vasc Endovasc Surg. 2021. 61. 1. 467-472
